Interaction Between Direct Factor Xa Inhibitors and Digoxin
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
|---|---|
| Enthalten in: |
American journal of therapeutics - 26(2019), 5 vom: 03. Sept., Seite e649-e652 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sokol, Juraj [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
3Z9Y7UWC1J |
|---|
| Anmerkungen: |
Date Completed 05.02.2020 Date Revised 05.02.2020 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1097/MJT.0000000000000851 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM288887387 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM288887387 | ||
| 003 | DE-627 | ||
| 005 | 20231225061329.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/MJT.0000000000000851 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0962.xml |
| 035 | |a (DE-627)NLM288887387 | ||
| 035 | |a (NLM)30252680 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sokol, Juraj |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Interaction Between Direct Factor Xa Inhibitors and Digoxin |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.02.2020 | ||
| 500 | |a Date Revised 05.02.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Clinical Trial | |
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Cardiotonic Agents |2 NLM | |
| 650 | 7 | |a Factor Xa Inhibitors |2 NLM | |
| 650 | 7 | |a Pyrazoles |2 NLM | |
| 650 | 7 | |a Pyridones |2 NLM | |
| 650 | 7 | |a apixaban |2 NLM | |
| 650 | 7 | |a 3Z9Y7UWC1J |2 NLM | |
| 650 | 7 | |a Digoxin |2 NLM | |
| 650 | 7 | |a 73K4184T59 |2 NLM | |
| 650 | 7 | |a Rivaroxaban |2 NLM | |
| 650 | 7 | |a 9NDF7JZ4M3 |2 NLM | |
| 700 | 1 | |a Nehaj, Frantisek |e verfasserin |4 aut | |
| 700 | 1 | |a Ivankova, Jela |e verfasserin |4 aut | |
| 700 | 1 | |a Mokan, Michal |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of therapeutics |d 1994 |g 26(2019), 5 vom: 03. Sept., Seite e649-e652 |w (DE-627)NLM093845677 |x 1536-3686 |7 nnns |
| 773 | 1 | 8 | |g volume:26 |g year:2019 |g number:5 |g day:03 |g month:09 |g pages:e649-e652 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1097/MJT.0000000000000851 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 26 |j 2019 |e 5 |b 03 |c 09 |h e649-e652 | ||